
MCO® Tech. is an original technology developed by the RnD Institute of Koru Pharma and represents the optimised conditions of the chemical reaction between the cross-linking agent and hyaluronic acid (HA)

ACAPLEX™ is a patented regenerative technology combining the KORU-ACA01 peptide with Bio-identical Type III Collagen to reinforce and protect the extracellular matrix. Designed for clinical applications, it delivers scientifically validated ECM regeneration, enzyme inhibition, and long-term structural stability.

HALOS™ is a multi-pathway system developed by Koru Pharma to address key factors associated with hair thinning. Powered by KORU–AHL peptides and a targeted ingredient system, HALOS™ supports follicle function, the hair growth phase, scalp balance, microcirculation and follicle structure